Ruben Maase

Credit Suisse International engages in the provision of financial products and services focused on client driven businesses. It operates through the following segments: Investment Bank, Capital Release Unit, and Corporate Centre. The company was founded on May 9, 1990 and is headquartered in London, the United Kingdom.

Bridgepoint Advisers Ltd (Bridgepoint Advisers) is a private equity subsidiary of Bridgepoint Group Ltd. founded in 1984. The firm is headquartered in London, United Kingdom.

Van Lanschot Kempen Investment Management NV (Van Lanschot Kempen) is a specialist wealth manager headquartered in Amsterdam, Netherlands. The firm was founded in 1991 and was formerly known as Kempen Capital Management NV. They are a wholly-owned subsidiary of Van Lanschot Kempen NV (AMS: VLK). Van Lanschot Kempen administers Dutch pension funds and provides integral asset management for Dutch institutional clients.

LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.

Gimv Nederland BV (Gimv-Nederland) is the Netherlands-based private equity subsidiary of GIMV Corporate Investment, which in turn is a subsidiary of Gimv NV (XB: GIMB) in Belgium. Established in 1983, Gimv-Nederland was formerly known as Halder Invest BV and became part of the Gimv Group in 2000. The firm is located in The Hague with additional offices in Frankfurt and Antwerp. Their clients include fund of funds, insurance companies, banks, corporations and pension funds.

Montagu Private Equity LLP (Montagu) is a private equity firm founded in 1968. The firm is headquartered in London, United Kingdom with an additional offices in Frankfurt, Luxembourg, New York, Paris and Warsaw.

Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies.

Vitruvian Partners LLP (Vitruvian Partners) is a private equity firm founded in 2006 by Ian Riley, Michael Risman, Toby Wyles, Mark Harford and David Nahama. The firm is headquartered London, the United Kingdom with offices across the globe.

AAC Capital Partners Management BV is a Northern European mid-market buy-out firm established by the former Dutch, Nordic and UK buy-out teams of ABN AMRO Capital. AAC Capital Partners Management BV is headquartered in Amsterdam, the Netherlands.

AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.

International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries.

Vrumona BV engages in the manufacture and supply of beverages. Its brands include Sir Joe: Craft Soda, Sourcy, Pepsi, SiSi, 7UP, Gatorade, Climax, Royal Club, Rivella, Ranja, and Crystal Clear. The company was founded by Anton van Dam in June 16, 1945 and is headquartered in Bunnik, the Netherlands.

Part of McKinsey & Co., Inc., Mckinsey & Co. /Amsterdam/ provides management consultancy services. The company is based in Amsterdam, Netherlands.

Panaxea BV provides science based solutions for biomedical companies. It operates as a management and consulting firm. The firm specializes in biomedical business development, business management support, and health economics. The company was founded by Maarten J. Ijzerman in 2010 and is headquartered in Amsterdam, the Netherlands.

Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France.

Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.

Oaklins NV provides financial investment services. It focuses on mergers and acquisitons, growth equity and ECM, debt advisory, and corporate finance advisory services. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands.

Stichting Instituut Nederlandse Kwaliteit operates as a membership organization.

MiddleGround Management LP (MiddleGround Capital) is a private equity firm founded in 2018 by John Stewart and Lauren Mulholland. The firm is headquartered in Lexington, Kentucky.

Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson.

Ice Lake Capital Management BV (IceLake Capital) is a private equity firm founded in 2018 by Bastiaan Hagenouw, Matteo Racca and Vincent Lüning. The firm is headquartered in Amsterdam, the Netherlands.

ABN AMRO Asset Based Finance N.V., Niederlassung Deutschland operates a financial leasing institution. The company is based in Cologne, Germany. The German company is a subsidiary of ABN AMRO Bank N.V. and ultimately controlled by the Government of the Netherlands. The company was founded in 1990. The CEO is Kees C. van Dijkhuizen.

Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022.

Gain.pro BV engages in the design, development, and operation of a platform which provides disruptive services to the private equity industry. The firm offers Gain.pro which identifies, screens, and benchmarks businesses for clients. The company was founded by Frister Haveman and Nicola Ebmeyer and is headquartered in Amsterdam, the Netherlands.

Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA.

Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist.

EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands.

Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts.

Part of Stichting Cito Instituut Voor Toetsontwikkeling, Cito BV is a Dutch company that provides tests, exams, tracking systems, certification, and research for both education and organizations. Founded in 1968, the company is based in Arnhem, Netherlands. Cito's new student tracking system, In Beeld, focuses on student growth, while their central exams provide tools and information for teachers, such as Wolf, Mix & Meet, exam reports, and more. The company is committed to providing equal opportunities for everyone.